Migraine Migraine Sumatriptan does not prevent other migraine headaches from starting in the future.  For increased effectiveness at stopping migraine symptoms, a combined therapy that includes sumatriptan and naproxen may be suggested. Calcitonin gene-related peptide receptor antagonists  target calcitonin gene-related peptide or its receptor to prevent migraine headaches or reduce their severity.  CGRP is a signaling molecule as well as a potent vasodilator that is involved in the development of a migraine headache.  There are four injectable monoclonal antibodies that target CGRP or its receptor  and the medications have demonstrated efficacy in the preventative treatment of episodic and chronic migraine headaches in phase III randomized clinical trials. Zavegepant was approved for medical use in the United States in March 2023. Ergotamine and dihydroergotamine are older medications still prescribed for migraines, the latter in nasal spray and injectable forms Migraine Migraine